Finding ways to identify and treat sepsis before it becomes critical
Identifying pre-sepsis opportunities for early, targeted intervention
This study is looking for ways to spot early signs of sepsis, a serious infection, before people even get to the hospital, so that we can help those at risk and prevent the condition from getting worse.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-10874403 on NIH RePORTER |
What this research studies
This research focuses on discovering early signs of sepsis, a life-threatening condition caused by infection, before patients reach the hospital. By analyzing electronic health records and using advanced artificial intelligence techniques, the team aims to identify patients at risk of developing sepsis and develop targeted interventions to prevent its progression. The study will rigorously test prediction models and validate their effectiveness in real-time clinical settings, potentially leading to new pre-hospital care strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at high risk for infections that could lead to sepsis, particularly those with chronic health conditions or recent surgeries.
Not a fit: Patients who are not at risk for infections or those who do not present with any symptoms of sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce sepsis-related deaths by enabling earlier intervention and treatment.
How similar studies have performed: Previous research has shown promise in using early identification and intervention strategies for sepsis, indicating that this approach could lead to significant advancements in patient care.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Liu, Vincent — Kaiser Foundation Research Institute
- Study coordinator: Liu, Vincent
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.